NARA Discovery
Article Details
← Back to Search Results
Journal Article

Increased Expression of Transferrin Receptor 1 in the Brain Cortex of 5xFAD Mouse Model of Alzheimer’s Disease Is Associated with Activation of HIF-1 Signaling Pathway

Sabrina Petralla; Liudmila Saveleva; Katja M. Kanninen; Julia S. Oster; Maria Panayotova; Gert Fricker; Elena Puris
Molecular Neurobiology · Vol. 61, Issue 9 · pp. 6383-6394 · 2024

Abstract

Alzheimer’s disease (AD) is the most common cause of dementia. Despite intensive research efforts, there are currently no effective treatments to cure and prevent AD. There is growing evidence that dysregulation of iron homeostasis may contribute to the pathogenesis of AD. Given the important role of the transferrin receptor 1 (TfR1) in regulating iron distribution in the brain, as well as in the drug delivery, we investigated its expression in the brain cortex and isolated brain microvessels from female 8-month-old 5xFAD mice mimicking advanced stage of AD. Moreover, we explored the association between the TfR1 expression and the activation of the HIF-1 signaling pathway, as well as oxidative stress and inflammation in 5xFAD mice. Finally, we studied the impact of Aβ 1–40 and Aβ 1–42 on TfR1 expression in the brain endothelial cell line hCMEC/D3. In the present study, we revealed that an increase in TfR1 protein levels observed in the brain cortex of 5xFAD mice was associated with activation of the HIF-1 signaling pathway as well as accompanied by oxidative stress and inflammation. Interestingly, incubation of Aβ peptides in hCMEC/D3 cells did not affect the expression of TfR1, which supported our findings of unaltered TfR1 expression in the isolated brain microvessels in 5xFAD mice. In conclusion, the study provides important information about the expression of TfR1 in the 5xFAD mouse model and the potential role of HIF-1 signaling pathway in the regulation of TfR1 in AD, which could represent a promising strategy for the development of therapies for AD.

Bibliographic Information

JournalMolecular Neurobiology
PublisherSpringer
Publication Date2024-09-01
Publication Year2024
Volume61
Issue9
Pages6383-6394
Document TypeJournal Article
Print ISSN0893-7648
eISSN1559-1182
DOI10.1007/s12035-024-03990-3

Access Information

NARA Access Coverage1987-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12035
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.